Precision medicine

Liquid biopsy can help us appropriately treat patients with anti-PD-L1 immunotherapies, and ddPCR enables ongoing monitoring and adjustment of treatment

For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging, even if blood screening tests become a reality

Researchers from Penn State examine the 16p11.2 deletion for its role in neurodevelopmental disorders and related phenotypes

A new approach, wide-field mid-IR microscopy, can help identify biomarkers and diagnose and classify cancers without the need for labeling

Looking at miRNA expression levels may improve our ability to subtype bladder cancers and provide the most appropriate and effective treatment

The need for continuous and contextual biochemical data is clearer than ever, and enabling technology may be just around the corner

Broad NGS panels work well for cancer screening, but for monitoring, we need tools that are less expensive and more targeted

iPSC-based and genome editing approaches to the study of cardiac channelopathies may be the next step toward personalizing diagnosis and treatment

When it comes to liver pathology, what are the most essential tools for the job?

Better lung cancer treatment through biomarkers